April seven, 2020 — The use of the anti-malarial drug chloroquine to take care of COVID-19 people has been halted at quite a few Swedish hospitals because of to documented facet consequences these as cramps and decline of peripheral vision.

Sahlgrenska College Hospital is a single of those amenities. It stopped the use of chloroquine in the treatment method of COVID-19 about two weeks ago.

“There have been experiences of suspected more really serious facet consequences than we to start with believed,” Magnus Gisslen, a professor and main physician at Sahlgrenska College Hospital infection clinic, advised the Gothenburg Submit on April 1, Newsweek documented.

“We are not able to rule out really serious facet consequences, especially from the coronary heart, and it is a difficult-dosed drug. In addition, we have no potent evidence that chloroquine has an impact on COVID-19,” Magnus Gisslen reported.

No unique medicines are utilised to take care of COVID-19 but some persons have advocated the use of the anti-malarial medicines chloroquine and hydroxychloroquine.

U.S. President Donald Trump has touted the use of hydroxychloroquine in distinct and introduced Sunday that the federal govt experienced stockpiled 29 million hydroxychloroquine pills for the treatment method of COVID-19, Newsweek documented.

The use of hydroxychloroquine to take care of COVID-19 was permitted past thirty day period by the U.S. Food items and Drug Administration, even even though scientific studies of the two anti-malarial medicines have yielded combined effects.

For example, a single analyze discovered they supply no supplemental gain to COVID-19 people who are previously receiving antiviral medicines, Newsweek documented.

WebMD News from HealthDay


Copyright © 2013-2018 HealthDay. All rights reserved.